Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.

Autor: Unger JM; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Qian L; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Tavernier SS; Idaho State University, Pocatello, ID, USA., Minasian L; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA., Sigal EV; Friends of Cancer Research, Washington, DC, USA., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA., Leblanc M; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Cleeland CS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dzingle SA; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA., Summers TJ; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA., Chao H; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA., Madhusudhana S; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA., Villaruz L; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA., Crawford J; Duke Cancer Institute, Durham, NC, USA., Gray JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kelly KL; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Herbst RS; Yale Cancer Center, New Haven, CT, USA., Gettinger SN; Yale Cancer Center, New Haven, CT, USA., Moinpour CM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446.

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.

Autor: Gettinger SN; Yale Cancer Center, New Haven, Connecticut., Redman MW; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla., Hirsch FR; Mount Sinai Health System, New York, New York., Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento., Schwartz LH; Columbia University Medical College, New York, New York., Bradley JD; Washington University School of Medicine, St Louis, Missouri., Stinchcombe TE; Duke University School of Medicine, Durham, North Carolina., Leighl NB; Princess Margaret Hospital, Toronto, Ontario, Canada., Ramalingam SS; Department of Hematology and Oncology, Emory University, Atlanta, Georgia., Tavernier SS; Idaho State University School of Nursing, Pocatello., Yu H; Mount Sinai Health System, New York, New York., Unger JM; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Minichiello K; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Highleyman L; SWOG Statistical Center, Seattle, Washington., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston., Kelly K; University of California Davis Comprehensive Cancer Center, Sacramento., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento., Herbst RS; Yale Cancer Center, New Haven, Connecticut.

Publikováno v: JAMA oncology [JAMA Oncol] 2021 Sep 01; Vol. 7 (9), pp. 1368-1377.

Context Matters for Nurses Leading Pain Improvement in U.S. Hospitals.

Autor: Tavernier SS; From the College of Nursing, Idaho State University-Meridian, Meridian, ID, USA. Electronic address: tavesusa@isu.edu., Guo JW; College of Nursing, University of Utah, Salt Lake City, UT, USA., Eaton J; College of Nursing, University of Utah, Salt Lake City, UT, USA., Brant JM; Billings Clinic, Billings, MT, USA., Berry P; School of Nursing, Oregon Health and Science University, Portland, OR, USA., Beck SL; College of Nursing, University of Utah, Salt Lake City, UT, USA.

Publikováno v: Pain management nursing : official journal of the American Society of Pain Management Nurses [Pain Manag Nurs] 2018 Oct; Vol. 19 (5), pp. 474-486. Date of Electronic Publication: 2018 Aug 03.

A Conceptual Model for Home Based Primary Care of Older Refugees.

Autor: Nies MA; School of Nursing, Idaho State University, Pocatello, ID, USA.; Division of Health Sciences, Idaho State University, Pocatello, ID, USA., Febles C; Department of Global Studies and Languages, Idaho State University, 921 South 8th Avenue, STOP 8067, Pocatello, ID, 83209, USA. feblcarm@isu.edu., Fanning K; School of Nursing, Idaho State University, Pocatello, ID, USA.; Division of Health Sciences, Idaho State University, Pocatello, ID, USA., Tavernier SS; School of Nursing, Idaho State University, Pocatello, ID, USA.; Division of Health Sciences, Idaho State University, Pocatello, ID, USA.

Publikováno v: Journal of immigrant and minority health [J Immigr Minor Health] 2018 Apr; Vol. 20 (2), pp. 485-491.

Translating research on the distress thermometer into practice.

Autor: Tavernier SS; School of Nursing, Idaho State University in Meridian.

Publikováno v: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2014; Vol. 18 Suppl, pp. 26-30.